» Articles » PMID: 25239849

Effects of Cholecalciferol Supplementation and Optimized Calcium Intakes on Vitamin D Status, Muscle Strength and Bone Health: a One-year Pilot Randomized Controlled Trial in Adults with Severe Burns

Overview
Journal Burns
Publisher Elsevier
Date 2014 Sep 21
PMID 25239849
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Burn patients are at risk of hypovitaminosis D and osteopenia or sarcopenia. Vitamin D pleiotropic effects may influence bone and muscle health. The aim of this pilot study was to assess effects of a cholecalciferol (VD3) supplementation and an optimized calcium (Ca) regimen on vitamin D (VD) status, bone and muscle health during sequelar stage of burn injury.

Design: Monocentric randomized controlled trial.

Methods: Fifteen adults with thermal burns dating from 2 to 5 years were randomized into two groups. For 12 months, they either received a quarterly IM injection of 200,000IU VD3 and daily oral Ca (Group D) or placebo (Group P). VD status and bone remodeling markers were assessed every 3 months. Knee muscle strength and bone mineral density were, respectively, assessed using isokinetic dynamometry and dual X-ray absorptiometry at initiation (M0) and completion (M12) of the protocol.

Results: Of all the patients, 66% presented with VD deficiency and 53% (with 3 men <40y) were considered osteopenic at inclusion. After one year, calcidiol levels significantly increased in Group D to reach 40 (37-61)ng/ml. No significant change in bone health was observed in both groups while Group D significantly improved quadriceps strength when tested at high velocity.

Conclusions: This VD3 supplementation was safe and efficient to correct hypovitaminosis D in burn adults. When combined with optimized Ca intakes, it demonstrated positive effects on muscle health but not on bone health. A high prevalence of hypovitaminosis D and osteopenia in these patients, as well as their wide range of muscle performances, seem to be worrying when considering rehabilitation and quality of life.

Citing Articles

Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review.

Haber Mellen R, Girotto O, Marques E, Fornari Laurindo L, Grippa P, Mendes C Biomedicines. 2023; 11(1).

PMID: 36672642 PMC: 9856128. DOI: 10.3390/biomedicines11010136.


Is calcium a link between inflammatory bone resorption and heart disease?.

Klein G Elife. 2022; 11.

PMID: 36580074 PMC: 9799968. DOI: 10.7554/eLife.83841.


Long-term outcomes after critical illness: recent insights.

Rousseau A, Prescott H, Brett S, Weiss B, Azoulay E, Creteur J Crit Care. 2021; 25(1):108.

PMID: 33731201 PMC: 7968190. DOI: 10.1186/s13054-021-03535-3.


Oral Nutrition during and after Critical Illness: SPICES for Quality of Care!.

Fadeur M, Preiser J, Verbrugge A, Misset B, Rousseau A Nutrients. 2020; 12(11).

PMID: 33202634 PMC: 7696881. DOI: 10.3390/nu12113509.


Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss.

Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies I, Stewart C Geroscience. 2020; 42(6):1547-1578.

PMID: 33001410 PMC: 7528158. DOI: 10.1007/s11357-020-00272-3.